APA (7th ed.) Citation

Zenz, T. (2012). Risk categories and refractory CLL in the era of chemoimmunotherapy. Blood, 119(18), . https://doi.org/10.1182/blood-2011-11-312421

Chicago Style (17th ed.) Citation

Zenz, Thorsten. "Risk Categories and Refractory CLL in the Era of Chemoimmunotherapy." Blood 119, no. 18 (2012). https://doi.org/10.1182/blood-2011-11-312421.

MLA (9th ed.) Citation

Zenz, Thorsten. "Risk Categories and Refractory CLL in the Era of Chemoimmunotherapy." Blood, vol. 119, no. 18, 2012, https://doi.org/10.1182/blood-2011-11-312421.